34 Chapter 2 References 1. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; HM Government/Wellcome Trust: London, UK, 2016. 2. WHO. Factsheet Antimicrobial Resistance; WHO: Geneva, Switzerland, 2021. 3. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. 4. Davis, K.A.; Stewart, J.J.; Crouch, H.K.; Florez, C.E.; Hospenthal, D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 2004, 39, 776–782. 5. von Eiff, C.; Becker, K.; Machka, K.; Stammer, H.; Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N. Engl. J. Med. 2001, 344, 11–16. 6. Turner, N.A.; Sharma-Kuinkel, B.K.; Maskarinec, S.A.; Eichenberger, E.M.; Shah, P.P.; Carugati, M.; Holland, T.L.; Fowler, V.G., Jr. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 2019, 17, 203–218. 7. WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe 2022–2020 Data; WHO Regional Office for Europe: Copenhagen, Denmark, 2022. 8. Gorwitz, R.J.; Kruszon-Moran, D.; McAllister, S.K.; McDougal, L.K.; McQuillan, G.; Fosheim, G.E.; Kuehnert, M.J. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J. Infect. Dis. 2008, 197, 1226–1234. 9. Dutch Working Party on Infection Prevention (WIP) MRSA Hospitals; WIP: Leiden, The Netherlands, 2017. 10. Souverein, D.; Kruszon-Moran, D.; McAllister, S.K.; McQuillan, G.; McDougal, L.K.; Fosheim, G.E.; Jensen, B.J.; Killgore, G.; Tenover, F.C.; Kuehnert, M.J. Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands. PLoS ONE 2016, 11, e0148175. 11. Vos, M.C.; Behrendt, M.D.; Melles, D.C.; Mollema, F.P.N.; de Groot, W.; Parlevliet, G.; Ott, A.; Horst-Kreft, D.; van Belkum, A.; Verbrugh, H.A. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control. Hosp. Epidemiol. 2009, 30, 977–984. 12. Wertheim, H.; Vos, M.; Boelens, H.; Voss, A.; Vandenbroucke-Grauls, C.; Meester, M.; Kluytmans, J.; van Keulen, P.; Verbrugh, H. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: The value of search and destroy and restrictive antibiotic use. J. Hosp. Infect. 2004, 56, 321–325. 13. Health Council of the Netherlands. MRSA Policy in the Netherlands; Publication No. 2006/17. [Gezondheidsraad. MRSA-beleid in Nederland]; Health Council of the Netherlands: The Hague, The Netherlands, 2006. 14. van Rijen, M.M.; Kluytmans, J.A. Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28, 1245–1252. 15. Huang, S.S.; Singh, R.; McKinnell, J.A.; Park, S.; Gombosev, A.; Eells, S.J.; Gillen, D.L.; Kim, D.; Rashid, S.; Macias-Gil, R.; et al. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N. Engl. J. Med. 2019, 380, 638–650. 16. Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Ellerbroek, L.J.; Koster, T.; Hira, V.; Visser, L.G.; de Boer, M.G.J.; Lambregts, M.M.C. Complicated Carriage with Methicillin-Resistant Staphylococcus aureus: Evaluation of the Effectiveness of Decolonization Regimens Advised in the Dutch National Guideline. Antimicrob. Agents Chemother. 2021, 65,
RkJQdWJsaXNoZXIy MTk4NDMw